Close Menu

A Tech Review blog post discusses the work of Richard Lifton, who studies human outliers, so-called "extreme phenotypes" -- including a man with extremely high bone density. Lifton found a link to bone density with a mutation in the LDL-related receptor protein 5 gene and, now, a drug targeting part of that molecular pathway is in clinical testing to treat osteoporosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.